Ensign Peak Advisors’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,282
| Closed | -$83K | – | 2321 |
|
|
2022
Q2 | $83K | Sell |
26,282
-63,166
| -71% | -$199K | ﹤0.01% | 1996 |
|
|
2022
Q1 | $552K | Hold |
89,448
| – | – | ﹤0.01% | 1506 |
|
|
2021
Q4 | $1.27M | Buy |
89,448
+6,380
| +8% | +$90.7K | ﹤0.01% | 1158 |
|
|
2021
Q3 | $665K | Sell |
83,068
-95,000
| -53% | -$761K | ﹤0.01% | 1560 |
|
|
2021
Q2 | $5.09M | Buy |
178,068
+19,460
| +12% | +$556K | 0.01% | 645 |
|
|
2021
Q1 | $4.61M | Buy |
158,608
+110,442
| +229% | +$3.21M | 0.01% | 657 |
|
|
2020
Q4 | $575K | Buy |
48,166
+18,569
| +63% | +$222K | ﹤0.01% | 1575 |
|
|
2020
Q3 | $204K | Buy |
+29,597
| New | +$204K | ﹤0.01% | 1663 |
|